Journal of Infection
Volume 56, Issue 2 , Pages 99-102 , February 2008

Invasive pneumococcal disease in an underimmunized, high HIV prevalence population

  • Azadeh Tasslimi

      Affiliations

    • UMDNJ – School of Public Health, 65 Bergen Street, Newark, NJ 07107, USA
    • ,
  • Peter Wenger

      Affiliations

    • UMDNJ – School of Public Health, 65 Bergen Street, Newark, NJ 07107, USA
    • UMDNJ – New Jersey Medical School, 185 South Orange Avenue, MSB F506, Newark, NJ 07101, USA
    • UMDNJ – University Hospital, 150 Bergen Street, Newark, NJ 07103, USA
    • ,
  • Sri Ram Pentakota

      Affiliations

    • UMDNJ – School of Public Health, 65 Bergen Street, Newark, NJ 07107, USA
    • ,
  • Michael Brimacombe

      Affiliations

    • UMDNJ – School of Public Health, 65 Bergen Street, Newark, NJ 07107, USA
    • UMDNJ – New Jersey Medical School, 185 South Orange Avenue, MSB F506, Newark, NJ 07101, USA
    • ,
  • Michele Burday

      Affiliations

    • UMDNJ – New Jersey Medical School, 185 South Orange Avenue, MSB F506, Newark, NJ 07101, USA
    • UMDNJ – University Hospital, 150 Bergen Street, Newark, NJ 07103, USA
    • ,
  • Anushua Sinha

      Affiliations

    • UMDNJ – School of Public Health, 65 Bergen Street, Newark, NJ 07107, USA
    • UMDNJ – New Jersey Medical School, 185 South Orange Avenue, MSB F506, Newark, NJ 07101, USA
    • UMDNJ – University Hospital, 150 Bergen Street, Newark, NJ 07103, USA
    • Corresponding Author InformationCorresponding author. UMDNJ – New Jersey Medical School, Preventive Medicine and Community Health 185 South Orange Avenue, MSB F506, Newark, NJ 07101, USA. Tel.: +1 973 972 6538; fax: +1 973 972 7625.

,Accepted 20 November 2007.

References 

  1. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348(19):1737–1746
  2. Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease – United States, 1998–2003. MMWR. 2005;54:893–896
  3. Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA. 2006;295:1668–1674
  4. Flannery B, Heffernan RT, Harrison LH, Ray SM, Reingold AL, Hadler J, et al. Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med. 2006;144:1–9
  5. Chu SY, Barker LE, Smith PJ. Racial/ethnic disparities in preschool immunizations: United States, 1996–2001. Am J Public Health. 2004;94:973–977
  6. Austrian R. The quellung reaction, a neglected microbiologic technique. Mt Sinai J Med. 1976;43(6):699–709
  7. Centers for Disease Control and Prevention. Estimated vaccination coverage with 3+ pneumococcal conjugate vaccine among children 19–35months of age by state and Immunization Action Plan (IAP) area – US, National Immunization Survey, Q1/2002–Q4/2005. Available at: http://www.cdc.gov/vaccines/stats-surv/imz-coverage.htm#nis. Accessed: March 13, 2007.
  8. NJDHSS – Division of HIV/AIDS Services. Prevalence rate of top ten cities with HIV/AIDS reported as of June 30, 2006: Newark. Available at: http://www.state.nj.us/health/aids/repa/impactcities/newark.pdf. Accessed: December 28, 2006.
  9. Children's Defense Fund . Improving children's health: understanding children's health disparities and promising approaches to address them. Washington, D.C: Children's Defense Fund; 2006;
  10. Flannery B, Schrag S, Bennett NM, Lynfield R, Harrison LH, Reingold A, et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA. 2004;291(18):2197–2203
  11. Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, et al. Invasive pneumococcal disease caused by non-vaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297(16):1784–1792
  12. Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, Kellenberg J, et al. Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization in infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007;26(6):468–472
  13. Tan TQ, Mason EO, Wald ER, Barson WJ, Schutze GE, Bradley JS, et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 2002;110(1 Pt 1):1–6
  14. Byington CL, Samore MH, Stoddard GJ, Barlow S, Dalay J, Korgenski K, et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the Intermountain West: emergence of non-vaccine serogroups. Clin Infect Dis. 2005;41(1):21–29

PII: S0163-4453(07)00819-5

doi: 10.1016/j.jinf.2007.11.005

Journal of Infection
Volume 56, Issue 2 , Pages 99-102 , February 2008

Article Tools

* Image Usage & Resolution